Talampanel.

Article Details

Citation
Copy to clipboard

Howes JF, Bell C

Talampanel.

Neurotherapeutics. 2007 Jan;4(1):126-9.

PubMed ID
17199027 [ View in PubMed
]
Abstract

Talampanel is a novel anticonvulsant that acts as an allosteric inhibitor of the AMPA receptor. Talampanel has a broad spectrum of action in animal models of epilepsy and neuroprotection. Clinical experience to date has been able to show effectiveness in reduction of seizures in patients with refractory partial seizures.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
TalampanelGlutamate receptor 1ProteinHumans
Unknown
Not AvailableDetails
TalampanelGlutamate receptor 2ProteinHumans
Unknown
Not AvailableDetails
TalampanelGlutamate receptor 3ProteinHumans
Unknown
Not AvailableDetails
TalampanelGlutamate receptor 4ProteinHumans
Unknown
Not AvailableDetails